Bibliography
- CHEN H-S V, PELLEGRINI JW,AGGARWAL SK et al: Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. Neurosci. (1992) 12:4427–4436.
- LIPTON SA: Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide. Trends Neurosci. (1993) 16:527–532.
- LIPTON SA, ROSENBERG PA: Excitatory amino acids as a final common pathway for neurologic disorders. N Engl. I Med. (1994) 330:613–622.
- CHEN H-S V, LIPTON SA: Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism. Physiol (Lond) (1997) 499:27–46.
- CHEN H-S V, WANG YE RAYUDU PV et al.: Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation. Neuroscience (1998) 86:1121–1132.
- REISBERG B, DOODY R, STOFFLER ASCHMITT F, FERRIS S, MOBIUS J: Memantine in Moderate-to-Severe Alzheimer's disease. N Engl. Med. (2003) 348:1333–1341.